| scholarly article | Q13442814 |
| P50 | author | Jason W. Locasale | Q41047918 |
| Andrew N Macintyre | Q55283734 | ||
| Christopher B Newgard | Q87867408 | ||
| P2093 | author name string | Laurence A Turka | |
| Makoto Inoue | |||
| Olga Ilkayeva | |||
| Xiaojing Liu | |||
| Mari L Shinohara | |||
| Paul A Smith | |||
| Laura P Hale | |||
| Jeffrey C Rathmell | |||
| Bhavana Priyadharshini | |||
| Kris C Wood | |||
| Peter S Winter | |||
| Nancie J MacIver | |||
| Rigel J Kishton | |||
| Amanda G Nichols | |||
| Valerie A Gerriets | |||
| Martin A Schneider | |||
| Lea Haeberli | |||
| Catherine Huck | |||
| Marta E Slawinska | |||
| P2860 | cites work | Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology | Q21129303 |
| Site specificity of four pyruvate dehydrogenase kinase isoenzymes toward the three phosphorylation sites of human pyruvate dehydrogenase | Q24291531 | ||
| Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism | Q24300524 | ||
| Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1 | Q24336199 | ||
| Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol | Q24336876 | ||
| Understanding the Warburg effect: the metabolic requirements of cell proliferation | Q24604760 | ||
| Posttranscriptional control of T cell effector function by aerobic glycolysis | Q24606942 | ||
| Acylcarnitines: reflecting or inflicting insulin resistance? | Q27004603 | ||
| The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells | Q27860620 | ||
| Metabolic modulation of glioblastoma with dichloroacetate | Q28282255 | ||
| Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain | Q29614225 | ||
| Differentiation of effector CD4 T cell populations (*) | Q29614838 | ||
| NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis | Q30519470 | ||
| The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation | Q34242691 | ||
| IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6 | Q34521302 | ||
| The CD28 signaling pathway regulates glucose metabolism | Q34525357 | ||
| Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases | Q34615216 | ||
| HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells | Q35102340 | ||
| Attenuation of experimental colitis in glutathione peroxidase 1 and catalase double knockout mice through enhancing regulatory T cell function | Q35151625 | ||
| Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. | Q35404457 | ||
| Estrogen-related receptor-α is a metabolic regulator of effector T-cell activation and differentiation | Q35546707 | ||
| The role of low-level lactate production in airway inflammation in asthma | Q35786791 | ||
| Fuel feeds function: energy metabolism and the T-cell response | Q36292868 | ||
| Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. | Q36639793 | ||
| Sterol regulatory element-binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity | Q36839721 | ||
| Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation | Q36903810 | ||
| Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways. | Q36995837 | ||
| Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival | Q37199519 | ||
| Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. | Q37200886 | ||
| Dichloroacetate induces protective autophagy in LoVo cells: involvement of cathepsin D/thioredoxin-like protein 1 and Akt-mTOR-mediated signaling | Q37357063 | ||
| Dichloroacetate alleviates development of collagen II-induced arthritis in female DBA/1 mice | Q37454035 | ||
| Dichloroacetate should be considered with platinum-based chemotherapy in hypoxic tumors rather than as a single agent in advanced non-small cell lung cancer | Q37612417 | ||
| Development and quantitative evaluation of a high-resolution metabolomics technology | Q37696918 | ||
| The IL-17 differentiation pathway and its role in transplant outcome | Q37973866 | ||
| Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells | Q38714538 | ||
| A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence. | Q39150145 | ||
| Increased thioredoxin-1 production in human naturally occurring regulatory T cells confers enhanced tolerance to oxidative stress. | Q39285117 | ||
| Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC. | Q39695465 | ||
| Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo | Q39835139 | ||
| Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development | Q40760682 | ||
| Dichloroacetate at therapeutic concentration alters glucose metabolism and induces regulatory T-cell differentiation in alloreactive human lymphocytes | Q43532816 | ||
| Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance | Q44760628 | ||
| Piroxicam treatment of IL-10-deficient mice enhances colonic epithelial apoptosis and mucosal exposure to intestinal bacteria | Q46819055 | ||
| Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system. | Q53846430 | ||
| Naturally occurring regulatory T cells show reduced sensitivity toward oxidative stress-induced cell death | Q82807884 | ||
| Ablation of peroxiredoxin II attenuates experimental colitis by increasing FoxO1-induced Foxp3+ regulatory T cells | Q85949110 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 194-207 | |
| P577 | publication date | 2014-12-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation | |
| P478 | volume | 125 |
| Q38701511 | 6-mercaptopurine promotes energetic failure in proliferating T cells |
| Q64078967 | A Metabolism Toolbox for CAR T Therapy |
| Q38891307 | A guide to immunometabolism for immunologists. |
| Q36800650 | AMPK Is Essential to Balance Glycolysis and Mitochondrial Metabolism to Control T-ALL Cell Stress and Survival. |
| Q40540223 | Alkaline Cytosolic pH and High Sodium Hydrogen Exchanger 1 (NHE1) Activity in Th9 Cells. |
| Q60950933 | Anergy into T regulatory cells: an integration of metabolic cues and epigenetic changes at the Foxp3 conserved non-coding sequence 2 |
| Q49546319 | Antitumor T cell reconditioning: improving metabolic fitness for optimal cancer immunotherapy. |
| Q89947934 | Anxiolytic Drug FGIN-1-27 Ameliorates Autoimmunity by Metabolic Reprogramming of Pathogenic Th17 Cells |
| Q38635598 | Assessment of metabolic and mitochondrial dynamics in CD4+ and CD8+ T cells in virologically suppressed HIV-positive individuals on combination antiretroviral therapy |
| Q47126247 | Attenuation of CD4+CD25+ Regulatory T Cells in the Tumor Microenvironment by Metformin, a Type 2 Diabetes Drug |
| Q36586185 | Autophagy enforces functional integrity of regulatory T cells by coupling environmental cues and metabolic homeostasis |
| Q91497249 | Bile acid metabolites control TH17 and Treg cell differentiation |
| Q39313207 | Biochemical Underpinnings of Immune Cell Metabolic Phenotypes |
| Q38622052 | CCCTC-Binding Factor Translates Interleukin 2- and α-Ketoglutarate-Sensitive Metabolic Changes in T Cells into Context-Dependent Gene Programs. |
| Q50054341 | CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response. |
| Q36789958 | Cell surface Glut1 levels distinguish human CD4 and CD8 T lymphocyte subsets with distinct effector functions |
| Q33423703 | Complement Regulates Nutrient Influx and Metabolic Reprogramming during Th1 Cell Responses |
| Q37248499 | Complement-Mediated Regulation of Metabolism and Basic Cellular Processes |
| Q26781587 | Control of macrophage metabolism and activation by mTOR and Akt signaling |
| Q99711564 | Critical Role of AdipoR1 in Regulating Th17 Cell Differentiation Through Modulation of HIF-1α-Dependent Glycolysis |
| Q40409859 | Cutting Edge: Murine Mast Cells Rapidly Modulate Metabolic Pathways Essential for Distinct Effector Functions |
| Q57464697 | Cutting Edge: TGF-β and Phosphatidylinositol 3-Kinase Signals Modulate Distinct Metabolism of Regulatory T Cell Subsets |
| Q38737991 | Cytochrome c Oxidase Activity Is a Metabolic Checkpoint that Regulates Cell Fate Decisions During T Cell Activation and Differentiation |
| Q58390470 | DNA methylation regulates the neonatal CD4 T-cell response to pneumonia in mice |
| Q46475452 | Dichloroacetate induces regulatory T-cell differentiation and suppresses Th17-cell differentiation by pyruvate dehydrogenase kinase-independent mechanism |
| Q61800041 | Differential Regulation of Human Treg and Th17 Cells by Fatty Acid Synthesis and Glycolysis |
| Q62748170 | Differential T-cell receptor signals for T helper cell programming |
| Q53422663 | Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity. |
| Q58589986 | Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism |
| Q60303325 | Drp1 Controls Effective T Cell Immune-Surveillance by Regulating T Cell Migration, Proliferation, and cMyc-Dependent Metabolic Reprogramming |
| Q39272251 | Dysfunctional T cell metabolism in the tumor microenvironment |
| Q92072023 | ERα Signaling Increased IL-17A Production in Th17 Cells by Upregulating IL-23R Expression, Mitochondrial Respiration, and Proliferation |
| Q50098031 | Early TCR Signaling Induces Rapid Aerobic Glycolysis Enabling Distinct Acute T Cell Effector Functions. |
| Q40745622 | Emerging concepts of T cell metabolism as a target of immunotherapy. |
| Q92614033 | Enhanced oxidative phosphorylation in NKT cells is essential for their survival and function |
| Q94565400 | Entry of glucose- and glutamine-derived carbons into the citric acid cycle supports early steps of HIV-1 infection in CD4 T cells |
| Q99416008 | Exercise immunology: Future directions |
| Q49257611 | Exploiting immune cell metabolic machinery for functional HIV cure and the prevention of inflammaging. |
| Q47128955 | Exploring Non-Metabolic Functions of Glycolytic Enzymes in Immunity |
| Q57160050 | Fatty acid metabolism complements glycolysis in the selective regulatory T cell expansion during tumor growth |
| Q39223057 | Fine tuning of immunometabolism for the treatment of rheumatic diseases |
| Q47914208 | Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments. |
| Q46215374 | Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression |
| Q37624347 | Foxp3 drives oxidative phosphorylation and protection from lipotoxicity. |
| Q33834498 | From Krebs to clinic: glutamine metabolism to cancer therapy. |
| Q40232460 | Fuelling the mechanisms of asthma: Increased fatty acid oxidation in inflammatory immune cells may represent a novel therapeutic target. |
| Q92432963 | Functional reprogramming of regulatory T cells in the absence of Foxp3 |
| Q26747110 | Glucose Metabolism in T Cells and Monocytes: New Perspectives in HIV Pathogenesis |
| Q36387092 | Glucose Oxidation Is Critical for CD4+ T Cell Activation in a Mouse Model of Systemic Lupus Erythematosus. |
| Q40484358 | Glutamine-dependent α-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation |
| Q90658517 | Glutathione Restricts Serine Metabolism to Preserve Regulatory T Cell Function |
| Q58753648 | Glutathione de novo synthesis but not recycling process coordinates with glutamine catabolism to control redox homeostasis and directs murine T cell differentiation |
| Q36904140 | Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants |
| Q64083937 | HIF-1α Is a Metabolic Switch between Glycolytic-Driven Migration and Oxidative Phosphorylation-Driven Immunosuppression of Tregs in Glioblastoma |
| Q41678886 | HIF1α and metabolic reprogramming in inflammation. |
| Q38732972 | Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease |
| Q92342000 | Helper T cell differentiation |
| Q47551069 | Hexokinase II may be dispensable for CD4 T cell responses against a virus infection. |
| Q42198502 | Hif-1α Knockdown Reduces Glycolytic Metabolism and Induces Cell Death of Human Synovial Fibroblasts Under Normoxic Conditions |
| Q38854617 | High density lipoproteins selectively promote the survival of human regulatory T cells |
| Q89983091 | Histone H3K27me3 demethylases regulate human Th17 cell development and effector functions by impacting on metabolism |
| Q92482424 | Homeostasis and transitional activation of regulatory T cells require c-Myc |
| Q36952049 | Homocysteine activates T cells by enhancing endoplasmic reticulum-mitochondria coupling and increasing mitochondrial respiration |
| Q91339440 | How to reprogram microglia toward beneficial functions |
| Q40097257 | Human Leukocyte Antigen (HLA) and Immune Regulation: How Do Classical and Non-Classical HLA Alleles Modulate Immune Response to Human Immunodeficiency Virus and Hepatitis C Virus Infections? |
| Q89882621 | Hyperactive PI3Kδ predisposes naive T cells to activation via aerobic glycolysis programs |
| Q26781659 | Hyperpolarized (13)C Magnetic Resonance and Its Use in Metabolic Assessment of Cultured Cells and Perfused Organs |
| Q49725890 | Hypoxia Pathway Proteins As Central Mediators of Metabolism in the Tumor Cells and Their Microenvironment. |
| Q37258774 | IKKβ promotes metabolic adaptation to glutamine deprivation via phosphorylation and inhibition of PFKFB3. |
| Q91808408 | ILC3s integrate glycolysis and mitochondrial production of reactive oxygen species to fulfill activation demands |
| Q90050590 | Immunometabolic Checkpoints of Treg Dynamics: Adaptation to Microenvironmental Opportunities and Challenges |
| Q37712496 | Immunometabolic Regulation of Interleukin-17-Producing T Helper Cells: Uncoupling New Targets for Autoimmunity. |
| Q50054528 | Immunometabolism and PI(3)K Signaling As a Link between IL-2, Foxp3 Expression, and Suppressor Function in Regulatory T Cells. |
| Q38937346 | Immunometabolism and autoimmunity |
| Q64054632 | Immunometabolism of Phagocytes and Relationships to Cardiac Repair |
| Q28074509 | Immunometabolism of regulatory T cells |
| Q50085942 | Immunometabolism, pregnancy, and nutrition. |
| Q92298634 | Immunometabolism: A target for the comprehension of immune response toward transplantation |
| Q38624726 | Immunometabolism: Cellular Metabolism Turns Immune Regulator |
| Q48046289 | Inhibiting Oxidative Phosphorylation In Vivo Restrains Th17 Effector Responses and Ameliorates Murine Colitis. |
| Q38686210 | Integrated regulation of the cellular metabolism and function of immune cells in adipose tissue |
| Q98665193 | Lactate modulation of immune responses in inflammatory versus tumour microenvironments |
| Q39738326 | Leptin directly promotes T-cell glycolytic metabolism to drive effector T-cell differentiation in a mouse model of autoimmunity |
| Q30252405 | Lineage-Specific Metabolic Properties and Vulnerabilities of T Cells in the Demyelinating Central Nervous System. |
| Q43097037 | MINK1: The missing link between ROS and its inhibition of Th17 cells |
| Q40097679 | Manipulating Glucose Metabolism during Different Stages of Viral Pathogenesis Can Have either Detrimental or Beneficial Effects |
| Q90043581 | Melanoma Metabolism: Cell Survival and Resistance to Therapy |
| Q89627075 | Memory T cells in transplantation: old challenges define new directions |
| Q64080801 | Merger of dynamic two-photon and phosphorescence lifetime microscopy reveals dependence of lymphocyte motility on oxygen in solid and hematological tumors |
| Q96348555 | Met-Flow, a strategy for single-cell metabolic analysis highlights dynamic changes in immune subpopulations |
| Q54985437 | Metabolic Adaptations of CD4+ T Cells in Inflammatory Disease. |
| Q61448742 | Metabolic Checkpoints in Differentiation of Helper T Cells in Tissue Inflammation |
| Q41437712 | Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression |
| Q92072375 | Metabolic Pathways Involved in Regulatory T Cell Functionality |
| Q39418546 | Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy |
| Q55285363 | Metabolic Reprogramming in Modulating T Cell Reactive Oxygen Species Generation and Antioxidant Capacity. |
| Q39313214 | Metabolic and Epigenetic Coordination of T Cell and Macrophage Immunity |
| Q90272929 | Metabolic checkpoints in neurodegenerative T helper 17 (TH17) and neuroregenerative regulatory T (Treg) cells as new therapeutic targets for multiple sclerosis |
| Q59256385 | Metabolic control of T cell immune response through glycans in inflammatory bowel disease |
| Q38786619 | Metabolic control of arthritis: Switch pathways to treat |
| Q92578624 | Metabolic coordination of T cell quiescence and activation |
| Q40049632 | Metabolic orchestration of T lineage differentiation and function |
| Q51617878 | Metabolic plasticity of human T cells: Preserved cytokine production under glucose deprivation or mitochondrial restriction, but 2-deoxy-glucose affects effector functions. |
| Q92569677 | Metabolic regulation of TH17 cells |
| Q39194474 | Metabolic regulation of inflammation |
| Q57181197 | Metabolic regulation of innate and adaptive lymphocyte effector responses |
| Q39244812 | Metabolic reprograming of anti-tumor immunity |
| Q39617623 | Metabolic reprogramming of alloantigen-activated T cells after hematopoietic cell transplantation |
| Q59418269 | Metabolic signaling directs the reciprocal lineage decisions of αβ and γδ T cells |
| Q47118555 | Metabolism Controls the Balance of Th17/T-Regulatory Cells. |
| Q40065267 | Metabolism in Immune Cell Differentiation and Function. |
| Q97424076 | Metabolism of immune cells in cancer |
| Q56418745 | Microenvironmental control of glucose metabolism in tumors by regulation of pyruvate dehydrogenase |
| Q26992186 | Mitochondria in the regulation of innate and adaptive immunity |
| Q55100716 | Mitochondria: An Organelle of Bacterial Origin Controlling Inflammation. |
| Q92296866 | Mitochondrial Integrity Regulated by Lipid Metabolism Is a Cell-Intrinsic Checkpoint for Treg Suppressive Function |
| Q36562453 | Mitochondrial Membrane Potential Identifies Cells with Enhanced Stemness for Cellular Therapy. |
| Q90044590 | Mitochondrial Pyruvate Carrier 1 Promotes Peripheral T Cell Homeostasis through Metabolic Regulation of Thymic Development |
| Q37262107 | Mitochondrial Respiration Controls Lysosomal Function during Inflammatory T Cell Responses. |
| Q90971059 | Mitochondrial complex III is essential for suppressive function of regulatory T cells |
| Q39410087 | Mitochondrial control of immunity: beyond ATP. |
| Q90608748 | Mitochondrial fidelity and metabolic agility control immune cell fate and function |
| Q45829514 | Molecular Mechanisms Modulating the Phenotype of Macrophages and Microglia |
| Q49990145 | Navigating T-Cell Immunometabolism in Transplantation. |
| Q33780993 | Ndfip1 restricts mTORC1 signalling and glycolysis in regulatory T cells to prevent autoinflammatory disease |
| Q92610514 | Noninvasive rapid detection of metabolic adaptation in activated human T lymphocytes by hyperpolarized 13C magnetic resonance |
| Q90721995 | Nur77 serves as a molecular brake of the metabolic switch during T cell activation to restrict autoimmunity |
| Q37689449 | Nutrient and Metabolic Sensing in T Cell Responses |
| Q39068014 | Nutritional effects on T-cell immunometabolism |
| Q50193692 | O-GlcNAc: a novel regulator of immunometabolism. |
| Q34538613 | Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic Niche. |
| Q36515067 | PKLR promotes colorectal cancer liver colonization through induction of glutathione synthesis |
| Q39434888 | Pathogenic Role of IL-17-Producing Immune Cells in Obesity, and Related Inflammatory Diseases |
| Q64106873 | Peptidoglycan Muropeptides: Release, Perception, and Functions as Signaling Molecules |
| Q99412452 | Peritoneal dialysate-range hypertonic glucose promotes T cell IL-17 production that induces mesothelial inflammation |
| Q59805349 | Progresses and Perspectives of Anti-PD-1/PD-L1 Antibody Therapy in Head and Neck Cancers |
| Q38806412 | Protein Kinase CK2 Controls the Fate between Th17 Cell and Regulatory T Cell Differentiation. |
| Q58792292 | Pyruvate dehydrogenase complex stimulation promotes immunometabolic homeostasis and sepsis survival |
| Q92884393 | Pyruvate kinase M2 is requisite for Th1 and Th17 differentiation |
| Q47620230 | Recipe for IBD: can we use food to control inflammatory bowel disease? |
| Q50026803 | Reciprocal Regulation of Glycolysis-Driven Th17 Pathogenicity and Regulatory T Cell Stability by Cdc42. |
| Q49861299 | Regulatory T Cell Metabolism in the Hepatic Microenvironment. |
| Q92489012 | Regulatory T cell adaptation in the intestine and skin |
| Q100694982 | Regulatory t cell metabolism at the intersection between autoimmune diseases and cancer |
| Q37357112 | Restoring oxidant signaling suppresses proarthritogenic T cell effector functions in rheumatoid arthritis |
| Q38957379 | Role of Metabolism in the Immunobiology of Regulatory T Cells |
| Q55315202 | Rotenone Treatment Reveals a Role for Electron Transport Complex I in the Subcellular Localization of Key Transcriptional Regulators During T Helper Cell Differentiation. |
| Q91755202 | Short-chain fatty acids: Bacterial messengers modulating the immunometabolism of T cells |
| Q39418532 | Similarities and Distinctions of Cancer and Immune Metabolism in Inflammation and Tumors |
| Q93016064 | Solute carrier transporters: the metabolic gatekeepers of immune cells |
| Q40246921 | Suppression of Th17 cell differentiation by misshapen/NIK-related kinase MINK1. |
| Q38566464 | Synchronizing transcriptional control of T cell metabolism and function |
| Q96303611 | T Cell Metabolism: A New Perspective on Th17/Treg Cell Imbalance in Systemic Lupus Erythematosus |
| Q91645219 | T cell Metabolism in Lupus |
| Q35371293 | T cell metabolic fitness in antitumor immunity |
| Q38567424 | T cell metabolic reprogramming and plasticity |
| Q26799575 | T cell metabolism drives immunity |
| Q92712487 | T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy |
| Q38915095 | T-cell metabolism governing activation, proliferation and differentiation; a modular view |
| Q92001038 | TCR Dependent Metabolic Programming Regulates Autocrine IL-4 Production Resulting in Self-Tuning of the CD8+ T Cell Activation Setpoint |
| Q57815155 | TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy |
| Q91536702 | Targeted Metabolic Reprogramming to Improve the Efficacy of Oncolytic Virus Therapy |
| Q46792366 | Targeting HIF-1α/PDK1 Axis by Dichloroacetate (DCA) Suppresses Bleomycin-induced Pulmonary Fibrosis |
| Q39099620 | Targeting Metabolism as a Novel Therapeutic Approach to Autoimmunity, Inflammation, and Transplantation |
| Q90681179 | Targeting T Cell Metabolism in Inflammatory Skin Disease |
| Q39315870 | Targeting T cell metabolism to regulate T cell activation, differentiation and function in disease |
| Q92297313 | Targeting metabolism to regulate immune responses in autoimmunity and cancer |
| Q41859862 | Th17 Polarization under Hypoxia Results in Increased IL-10 Production in a Pathogen-Independent Manner |
| Q47585318 | Th17/Treg immunoregulation and implications in treatment of sulfur mustard gas-induced lung diseases |
| Q38991066 | The "ins and outs" of complement-driven immune responses. |
| Q37729333 | The Glyoxalase System and Methylglyoxal-Derived Carbonyl Stress in Sepsis: Glycotoxic Aspects of Sepsis Pathophysiology |
| Q90176770 | The Impact of Dietary Components on Regulatory T Cells and Disease |
| Q38919518 | The PI3K pathway in B cell metabolism |
| Q36596905 | The Proteomic Landscape of Human Ex Vivo Regulatory and Conventional T Cells Reveals Specific Metabolic Requirements |
| Q49630753 | The Role of Lipid Metabolism in T Lymphocyte Differentiation and Survival. |
| Q58114531 | The Role of PPAR-δ in Metabolism, Inflammation, and Cancer: Many Characters of a Critical Transcription Factor |
| Q39032994 | The Therapeutic Potential of T Cell Metabolism. |
| Q39237471 | The bioenergetics of inflammation: insights into obesity and type 2 diabetes. |
| Q89915575 | The immunologic Warburg effect: Evidence and therapeutic opportunities in autoimmunity |
| Q47617054 | The impact of cellular metabolism on chromatin dynamics and epigenetics |
| Q96304966 | The numbers of peripheral regulatory T cells are reduced in patients with psoriatic arthritis and are restored by low-dose interleukin-2 |
| Q38984914 | The obesity-related pathology and Th17 cells. |
| Q39036066 | The role of caloric load and mitochondrial homeostasis in the regulation of the NLRP3 inflammasome |
| Q49853005 | The spectrum of T cell metabolism in health and disease. |
| Q38988403 | Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1. |
| Q55365838 | Thymic Program Directing the Functional Development of γδT17 Cells. |
| Q92409730 | Transcription Factor IRF4 Dysfunction Affects the Immunosuppressive Function of Treg Cells in Patients with Primary Immune Thrombocytopenia |
| Q49790388 | Transcriptional factor ICER promotes glutaminolysis and the generation of Th17 cells. |
| Q48638999 | Tumor-associated myeloid cells: new understandings on their metabolic regulation and their influence in cancer immunotherapy. |
| Q55478869 | Uncoupling of glycolysis from glucose oxidation accompanies the development of heart failure with preserved ejection fraction. |
| Q52727826 | Upregulation of Glucose Uptake and Hexokinase Activity of Primary Human CD4+ T Cells in Response to Infection with HIV-1. |
| Q93208179 | mTOR Inhibitor Everolimus in Regulatory T Cell Expansion for Clinical Application in Transplantation |
| Q28081442 | mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging |
| Q54966043 | mTOR coordinates transcriptional programs and mitochondrial metabolism of activated Treg subsets to protect tissue homeostasis. |
Search more.